Community Advisory Board for NF1

NF Patients United is delighted to announce the establishment of the Community Advisory Board (CAB) for Neurofibromatosis 1, led by NF Patients United.

The establishment of the CAB

The CAB will bring together NF1 patients and caregivers from across Europe to foster meaningful dialogue, share experiences, and provide valuable insights into the challenges faced by our community. CAB will work closely with the pharmaceutical industry, researchers, academics, government, policy makers and other stakeholders to advocate for the best possible research and access to treatment for patients.

Through collaboration and exchange, the CAB will work to:

  • Address key issues that NF patients / caregivers face
  • Provide input on research, policies, and programs
  • Foster partnerships between patients / caregivers, healthcare professionals, and policymakers

Getting involved in the CAB for NF1

You are a patient with NF1:
If you are interested to get involved in the NF1 Community Advisory Board and the educational training as a member please contact us at info@nf-patients.eu.

Company participation:
For companies who would like to contribute to the development of research and medicine for the rare disease Neurofibromatosis and would like to use the board of NF experts to advance their strategies, please contact: research@nf-patients.eu.

We are happy to hear from you!

Information updates on CAB activities will be published regularly on this page!

Our Sponsors

This important initiative is made possible through the generous support of our sponsors:

Leading Founding Sponsor:

We extend our heartfelt thanks to Alexion Pharmaceuticals, Inc. for their significant contribution and unwavering commitment to empowering patient voices.

Associate Founding Sponsor:

We are grateful to SpringWorks Therapeutics, Inc. for their support in helping us realize the vision of a patient-driven advisory board.

Together, with the support of our sponsors, the NF Community Advisory Board will pave the way for a more inclusive and patient-centered healthcare landscape.


EURORDIS rare diseases europe

Follow us:

© 2024 NF Patients United